European Commission 11 August 2020, COMMISSION STAFF WORKING DOCUMENT EXECUTIVE SUMMARY OF THE EVALUATION Joint evaluation of Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products
Also known as
European Union · · · 11-08-2020
1.Context In the 1980s and 1990s, the level of awareness concerning the lack of satisfactory treatments for patients with rare diseases and for children in the EU started to increase. The pharmaceutical industry showed insufficient interest in investing in the development of medicines for rare diseases and for children.
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network, article-level links and cross-references, which are available to search for free.
Sign in to Moonlit